Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis. Miller AE, O'Connor P, Wolinsky JS, Confavreux C, Kappos L, Olsson TP, Truffinet P, Wang L, D'Castro L, Comi G, et al. Mult Scler. 2012 Jun 21. Epub 1969 Dec 31. PMID: 22723573. Abstract CommentRecommendBookmarkWatch